I-CARE Program for Mental Health Disorders
(I-CARE Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: * Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program? * Does the I-CARE program lower patients' emotional distress, thoughts about suicide or suicide attempts? Patients will complete as many of the 7 I-CARE videos as possible during their stay at the medical hospital and fill out online surveys. There are workbook activities that go with each I-CARE video. A hospital staff member will help the patient do the videos and workbook activities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the I-CARE treatment for mental health disorders?
Research shows that programs focusing on patient education and involvement in treatment can lead to positive outcomes, such as reduced symptoms and increased engagement in recovery. Additionally, recovery-oriented models of care have shown significant improvements in social connection, symptoms, and self-belief, suggesting that similar approaches like I-CARE may be effective.12345
Is the I-CARE Program for Mental Health Disorders safe for humans?
How is the I-CARE treatment different from other treatments for mental health disorders?
The I-CARE treatment is unique because it focuses on internet-based interventions, which can improve access to mental health care by providing online support for conditions like depression, anxiety, substance abuse, and eating disorders. This approach can help bridge the gap for those waiting for face-to-face treatment and address access issues in different settings.3681112
Research Team
JoAnna K Leyenaar, MD, PhD, MPH
Principal Investigator
Dartmouth Health
Eligibility Criteria
This trial is for English-speaking children aged 12-17 who are in a medical hospital due to suicidal thoughts or attempts, waiting for mental health treatment. They must be supervised by a safety attendant and can start the day after they're medically cleared.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with the I-CARE program, completing as many of the 7 videos and workbook activities as possible during their hospital stay.
Follow-up
Participants are monitored for changes in emotional distress and suicidal ideation post-discharge.
Treatment Details
Interventions
- Improving Care, Accelerating Recovery & Education (ICARE)
Improving Care, Accelerating Recovery & Education (ICARE) is already approved in United States for the following indications:
- Mental health treatment for children awaiting inpatient care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
University of Vermont
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
Dartmouth College
Collaborator
Children's Hospital of Philadelphia
Collaborator
University of Vermont Medical Center
Collaborator